ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01034293
Recruitment Status : Completed
First Posted : December 17, 2009
Last Update Posted : July 23, 2010
Sponsor:
Collaborator:
Nederlandse Zuivel Organisatie
Information provided by:
Maastricht University Medical Center

Brief Summary:
The purpose of this study is to determine the effect of feeding frequency on glucose and insulin metabolism and substrate partitioning.

Condition or disease Intervention/treatment Phase
Insulin Glucose Metabolism Dietary Supplement: low feeding frequency (3x) Dietary Supplement: High feeding frequency (14x) Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning
Study Start Date : October 2009
Actual Primary Completion Date : March 2010
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

Drug Information available for: Insulin
U.S. FDA Resources

Arm Intervention/treatment
Experimental: low feeding frequency (3x) Dietary Supplement: low feeding frequency (3x)
3 meals a day
Experimental: High feeding frequency (14x) Dietary Supplement: High feeding frequency (14x)
14 meals a day



Primary Outcome Measures :
  1. Glucose and insulin metabolism [ Time Frame: 24 h ]

Secondary Outcome Measures :
  1. Substrate partitioning and metabolic markers [ Time Frame: 24 h ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI: 18.5-25 kg/m2 (lean)
  • Gender: Male
  • Age: subjects has to be older than 18 and including 35 years old
  • Caucasian

Exclusion Criteria:

  • Metabolic abnormalities such as:

    1. Lactose intolerant
    2. Diabetes Mellitus
    3. Hypertension
    4. Hypotension
    5. Cardiovascular diseases
    6. Asthma and other obstructive pulmonary diseases
    7. Elevated fasting blood glucose level

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01034293


Locations
Netherlands
University of Maastricht
Maastricht, Limburg, Netherlands, 6229 ER
Sponsors and Collaborators
Maastricht University Medical Center
Nederlandse Zuivel Organisatie
Investigators
Principal Investigator: WHM Saris, Prof. Dr. Maastricht University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Prof. dr. WHM Saris, University of Maastricht
ClinicalTrials.gov Identifier: NCT01034293     History of Changes
Other Study ID Numbers: MEC 09-3-032
First Posted: December 17, 2009    Key Record Dates
Last Update Posted: July 23, 2010
Last Verified: July 2010

Keywords provided by Maastricht University Medical Center:
feeding frequency
insulin metabolism
glucose metabolism
substrate partitioning

Additional relevant MeSH terms:
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs